Investors looking beyond U.S. equities often face a choice between broad, low-cost index replication and actively managed income generation. That distinction separates SCHF and IDVO. Schwab International Equity ETF (SCHF) delivers inexpensive, market-wide coverage of developed international markets, while Amplify International Enhanced Dividend Income ETF (IDVO) focuses on yield through a concentrated portfolio of dividend-paying American Depositary Receipts paired with a tactical options strategy. Although both sit under the international-equity category, they differ structurally and serve different goals. Comparing them highlights the trade-off between diversification and cost on one side, and income potential and active positioning on the other. I also checked sector overlaps using Tickeron’s AI Screener to confirm the thematic differences.
IDVO is an actively managed exchange-traded fund that invests in dividend-paying ADRs drawn from the MSCI ACWI ex USA Index universe. The fund overlays a tactical covered-call writing strategy on individual holdings to generate additional option premium income, aiming to supplement a dividend yield that has recently run well above broad international benchmarks. The portfolio is concentrated, holding roughly 50 to 66 names depending on the reporting period, with top positions including TSM, NTR, BMO, BABA, CCJ, MUFG, SMFG, AMX, AZN, and SCCO. Financials represent the largest sector allocation, followed by materials, technology, and utilities. Country exposure leans toward Canada, the United Kingdom, Japan, Taiwan, and a meaningful emerging-markets sleeve. IDVO carries a 0.65% expense ratio and, because the covered-call strategy can cap upside in strong rallies, its total-return profile differs meaningfully from a plain index fund.
SCHF is a passive, market-cap-weighted index fund that seeks to track the FTSE Developed ex-U.S. Index, a broad benchmark of large- and mid-capitalization companies in developed markets outside the United States. With roughly 1,400 holdings, it offers far greater breadth than IDVO, spreading single-stock risk across a diversified universe. Top holdings include ASML, Samsung Electronics, SK hynix, HSBC, Roche, RY, Shell, NVS, AZN, and MUFG, though no single position typically exceeds about 3% of assets. Sector exposure is dominated by financials, industrials, technology, and health care, with geographic weight concentrated in Japan, the United Kingdom, Canada, and continental Europe. SCHF charges an expense ratio of just 0.03%, making it one of the cheapest ways to access developed international equities, and its large asset base supports tight spreads and strong secondary-market liquidity. From what I see, the low fee structure stands out as a clear advantage for long-term holders.
Both funds operate in an environment where international equities have re-rated amid AI-driven demand for semiconductors, renewed interest in non-U.S. value and dividend segments, and shifting monetary policy expectations across Europe, Japan, and other developed economies. SCHF is heavily leveraged to the global semiconductor and AI-capital-expenditure cycle through Samsung Electronics, SK hynix, ASML, and Tokyo Electron, while also carrying substantial financials and health care exposure sensitive to interest rates and currency moves. IDVO, by contrast, tilts toward dividend-paying financials, miners, and telecom operators, making it more responsive to commodity prices, bank earnings, and income-investor demand. Key risks for both include currency fluctuations, geopolitical tensions, and slowing global growth, while the main divergence is that SCHF captures broad market beta and IDVO emphasizes current income and value characteristics. I’m watching this closely because the semiconductor tilt in SCHF could continue driving relative performance.
In recent market cycles, the two funds have been driven by different engines. SCHF's relative positioning has benefited from the strength of Asian and European semiconductor leaders and the breadth of developed-market earnings recovery, with its low fee base allowing investors to retain nearly all benchmark returns. IDVO has delivered comparatively high distributions, a function of its dividend focus and covered-call premiums, but its concentrated, value-oriented book can lag when growth and technology leadership dominate. Volatility profiles also differ: SCHF's thousands of underlying positions dilute idiosyncratic risk, while IDVO's roughly 55-name portfolio and options overlay produce a more idiosyncratic, income-tilted return stream. For investors prioritizing total-return participation across developed markets, SCHF's cost and diversification advantages are compelling; for those emphasizing income, IDVO fills a distinct niche.
I often rely on Tickeron’s AI Screener when comparing ETFs like these. It helps me quickly filter holdings by sector exposure, momentum signals, and cost metrics, which clarified why SCHF’s broad diversification stands out in the current environment. The tool also surfaced trend data that aligned with my view on semiconductor exposure. Overall, it streamlines the research process without replacing careful analysis of expense ratios and strategy differences.
Based on observable structural factors, Tickeron's AI would currently favor SCHF over IDVO. SCHF's 0.03% expense ratio, broad diversification across roughly 1,400 holdings, deep liquidity, and consistent exposure to high-momentum developed-market sectors provide a durable structural foundation. Its passive design removes active-management risk while capturing the ongoing semiconductor and industrial themes shaping international markets. IDVO's income generation is attractive, but its higher cost, concentrated portfolio, and capped upside from the covered-call overlay introduce frictions that weigh on its relative appeal in a momentum-driven environment. On cost efficiency, diversification profile, and trend consistency, SCHF holds the edge.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
The Moving Average Convergence Divergence (MACD) for SCHF turned positive on October 27, 2026. Looking at past instances where SCHF's MACD turned positive, the stock continued to rise in 37 of 42 cases over the following month. The odds of a continued upward trend are 88%.
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on SCHF as a result. In 69 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
Following a +0.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where SCHF advanced for three days, in 275 of 331 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
SCHF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The 10-day moving average for SCHF crossed bearishly below the 50-day moving average on September 24, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 79%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCHF declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
The Aroon Indicator for SCHF entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category ForeignLargeBlend